Literature DB >> 20065156

Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis.

Joseph A C Delaney1, Bruce E Oddson, Holly Kramer, Steven Shea, Bruce M Psaty, Robyn L McClelland.   

Abstract

Previous longitudinal cohort studies have suggested an association between baseline depressive symptoms and incident hypertension. We assessed this possible association using data from the Multi-ethnic Study of Atherosclerosis, a population-based prospective cohort study of 6814 US adults from 4 different racial/ethnic groups. Baseline users of antihypertensive medications and participants lost to follow-up were excluded leaving 3914 participants. Patients with baseline depressive symptoms (n=622) were defined using a high score on the Center for Epidemiological Studies Depression Scale (>or=16) or the use of an antidepressant medication. Hypertension was defined as systolic blood pressure of >or=140 mm Hg, diastolic blood pressure of >or=90 mm Hg or new use of antihypertensive medications plus physician diagnosis. Estimates were adjusted for known risk factors, including age, sex, baseline blood pressure, diabetes, and body mass index. Untreated blood pressure was estimated using an imputation approach. A total of 477 participants developed hypertension. Using relative risk regression, patients with baseline depressive symptoms did not have an increased risk of incident hypertension (relative risk: 1.02; 95% confidence interval [CI]: 0.99 to 1.05), although an association between tricyclic antidepressants and hypertension (relative risk: 1.20; 95% CI: 1.05 to 1.37) was observed in subgroup analysis. Depression, even after adjustment for covariates, was associated with small changes in systolic (+2.4 mm Hg; 95% CI: 0.2 to 4.7) and diastolic (+0.8 mm Hg; 95% CI: -0.6 to 2.3) blood pressures. Depressive symptoms may be associated with slight increases in blood pressure in this multiethnic cohort, but it is premature to conclude much without longer studies in other populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065156      PMCID: PMC2821214          DOI: 10.1161/HYPERTENSIONAHA.109.139824

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

Review 1.  Regression to the mean: what it is and how to deal with it.

Authors:  Adrian G Barnett; Jolieke C van der Pols; Annette J Dobson
Journal:  Int J Epidemiol       Date:  2004-08-27       Impact factor: 7.196

2.  Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease.

Authors:  Ana V Diez Roux; Nalini Ranjit; Lynda Powell; Sharon Jackson; Tené T Lewis; Steven Shea; Colin Wu
Journal:  Ann Intern Med       Date:  2006-06-06       Impact factor: 25.391

3.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure.

Authors:  Martin D Tobin; Nuala A Sheehan; Katrina J Scurrah; Paul R Burton
Journal:  Stat Med       Date:  2005-10-15       Impact factor: 2.373

4.  Validating the effects of drug treatment on blood pressure in the General Practice Research Database.

Authors:  Joseph A C Delaney; Erica E M Moodie; Samy Suissa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

5.  Relationships between depressive symptoms, anxiety, alcohol consumption, and blood pressure: results from the CARDIA Study. Coronary Artery Risk Development in Young Adults Study.

Authors:  R Jones-Webb; D R Jacobs; J M Flack; K Liu
Journal:  Alcohol Clin Exp Res       Date:  1996-05       Impact factor: 3.455

6.  Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study.

Authors:  Christina M Meyer; Haroutune K Armenian; William W Eaton; Daniel E Ford
Journal:  J Affect Disord       Date:  2004-12       Impact factor: 4.839

7.  Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands.

Authors:  A T Beekman; D J Deeg; J Van Limbeek; A W Braam; M Z De Vries; W Van Tilburg
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

8.  An imputation method for non-ignorable missing data in studies of blood pressure.

Authors:  N R Cook
Journal:  Stat Med       Date:  1997-12-15       Impact factor: 2.373

9.  Systemic hypertension associated with tricyclic antidepressant treatment in patients with panic disorder.

Authors:  A K Louie; E K Louie; R A Lannon
Journal:  Am J Cardiol       Date:  1992-11-15       Impact factor: 2.778

10.  The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.

Authors:  Zoe Fewell; George Davey Smith; Jonathan A C Sterne
Journal:  Am J Epidemiol       Date:  2007-07-05       Impact factor: 4.897

View more
  28 in total

1.  Depressive Symptoms, Antidepressant Use, and Hypertension in Young Adulthood.

Authors:  Danielle M Crookes; Ryan T Demmer; Katherine M Keyes; Karestan C Koenen; Shakira F Suglia
Journal:  Epidemiology       Date:  2018-07       Impact factor: 4.822

Review 2.  Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension.

Authors:  Heather M Johnson
Journal:  Curr Hypertens Rep       Date:  2019-07-18       Impact factor: 5.369

3.  Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients.

Authors:  Hiroyuki Kayano; Shinji Koba; Taiju Matsui; Hiroto Fukuoka; Kyouichi Kaneko; Makoto Shoji; Tsutomu Toshida; Norikazu Watanabe; Eiichi Geshi; Youichi Kobayashi
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

4.  Psychosocial Factors Are Associated With Blood Pressure Progression Among African Americans in the Jackson Heart Study.

Authors:  Cassandra D Ford; Mario Sims; John C Higginbotham; Martha R Crowther; Sharon B Wyatt; Solomon K Musani; Thomas J Payne; Ervin R Fox; Jason M Parton
Journal:  Am J Hypertens       Date:  2016-03-10       Impact factor: 2.689

Review 5.  Psychosocial risk factors for hypertension: an update of the literature.

Authors:  Yendelela Cuffee; Chinwe Ogedegbe; Natasha J Williams; Gbenga Ogedegbe; Antoinette Schoenthaler
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

6.  Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart Study.

Authors:  A J Shallcross; M Butler; R M Tanner; A P Bress; P Muntner; D Shimbo; G Ogedegbe; M Sims; T M Spruill
Journal:  J Hum Hypertens       Date:  2017-07       Impact factor: 3.012

7.  Depressive symptoms associated with physical health problems in midlife women: A longitudinal study.

Authors:  Holly J Jones; Pamela A Minarik; Catherine L Gilliss; Kathryn A Lee
Journal:  J Affect Disord       Date:  2019-12-02       Impact factor: 4.839

Review 8.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

Review 9.  Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study.

Authors:  Olga E Redina; Arcady L Markel
Journal:  Curr Hypertens Rep       Date:  2018-06-16       Impact factor: 5.369

10.  Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Álvaro Camacho; Robyn L McClelland; Joseph A Delaney; Matthew A Allison; Bruce M Psaty; Dena E Rifkin; Stephen R Rapp; Moyses Szklo; Murray B Stein; Michael H Criqui
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.